Patterns of Care in the Management of High-Risk COPD in the US (2011-2019) : An Observational Study for the CONQUEST Quality Improvement Program

Acknowledgments We acknowledge Frank Trudo, of AstraZeneca, for his contributions to the development and review of the protocol. We wish to acknowledge Tonya Winders for her valuable contributions to this publication. Writing, editorial support, and/or formatting assistance in the development of this manuscript was provided by Shilpa Suresh, MSc and Andrea Lim, BSc of the Observational and Pragmatic Research Institute, Singapore. Funding: This study was conducted by the Observational and Pragmatic Research Institute (OPRI) Pte Ltd and was partially funded by Optimum Patient Care Global and AstraZeneca Ltd. No funding was received by the Observational & Pragmatic Research Institute Pte Ltd (OPRI) for its contribution.Peer reviewedPublisher PD